Sex
Kisspeptin-10
Decapeptide · GPR54 ligand · 10 amino acids
FDA · INVESTIGATIONAL
Half-life
~28 minutes
Very short
minsdays
Route
SubQ injection
Evidence
Clinical trial data
Risk
Standard
Overview
Known for
Mechanism
Key facts
Format
Lyophilized powder
Mechanism targets
Classification
Active
Supply & nature
Natural / Topping UpNatural
FDA category
Investigational
Evidence & standing
Evidence base
Clinical trial data
Risk level
Standard
Clinical phase
Phase 2
Best studies
5 references
Dosage & protocol
Typical dose
50-100mcg
Research range
1–3 nmol/kg
Cycle
Per protocol
Onset
21 days first effects
Full effect
70 days
Half-life
~28min
~28 minutes (very short)
Protocol
Time to effects
Recommended vial
Reference figures only
Dosing reflects published laboratory protocols and is not guidance for use in any living subject.
Safety
Reversibility
Fully Reversible
Side effects
Interactions
Handle with research caution
Storage & handling
Lyophilised
12–24 months
2–8°C
Reconstituted
7–14 days
2–8°C
Videos & talks
Independent educational content from researchers, clinicians and science communicators — not affiliated with Pepnerd.
Educational resources only. Videos are independent third-party content. Pepnerd is not affiliated with these creators and does not endorse or make claims based on their content. All products are for in-vitro research.